Nimodipine in Acute Ischemic Stroke

Completed

Phase N/A Results

Results

Nimodipine was well tolerated and no severe cardiovascular adverse reactions were observed. The scores obtained by the Mathew Scale showed a higher rate of improvement on nimodipine than on placebo.